Expression of CD44 isoforms in human skin cancer

被引:27
|
作者
Simon, JC
Heider, KH
Dietrich, A
Wutting, C
Schopf, E
Adolf, GR
Ponta, H
Herrlich, P
机构
[1] BENDER & CO GMBH,VIENNA,AUSTRIA
[2] FORSCHUNGSZENTRUM KARLSRUHE,INST GENET,KARLSRUHE,GERMANY
关键词
CD44; isoforms; basal cell carcinoma; squamous cell carcinoma; malignant melanoma;
D O I
10.1016/0959-8049(96)00196-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In animal models, isoforms of CD44 (CD44v) containing sequences encoded by one or several of ten different exons (v1-v10) contribute to tumour metastasis. In certain human cancers, CD44v6 expression is associated with poor prognosis. This gaper examines CD44v expression in skin carcinogenesis and skin cancer metastasis. CD44v expression was studied in basal cell carcinoma (BCC), squamous cell carcinoma (SCC), primary malignant melanoma (MMM), metastases of IMM (MMM), benign melanocytic naevi (BMN) and normal skin (NS) by immunohistochemistry and reverse transcript polymerase chain reaction (RT-PCR). BCC, SCC and NS expressed several CD44v including v6, albeit in different distributions and intensities. PMM, MMM and BMN expressed isoforms containing v7/8 and v10, but failed to express epitopes encoded by v5 or v6. Thus, different CD44 isoforms are found in human skin cancers and ape modulated during carcinogenesis. However, we did not observe a correlation of CD44v6 expression with metastatic potential. Copyright (C) 1996 Published by Elsevier Science Ltd
引用
收藏
页码:1394 / 1400
页数:7
相关论文
共 50 条
  • [31] Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses
    Xia, Pu
    Xu, Xiao-Yan
    ONCOTARGET, 2016, 7 (29) : 45538 - 45546
  • [32] Alternative exon-specific PCR method for the analysis of human CD44 isoform expression
    Lockhart, MS
    Gravisaco, MJ
    Mongini, C
    Waldner, C
    Alvarez, E
    Hajos, SE
    ONCOLOGY REPORTS, 1999, 6 (01) : 219 - 224
  • [33] Characterization of the Expression of Variant and Standard CD44 in Prostate Cancer Cells: Identification of the Possible Molecular Mechanism of CD44/MMP9 Complex Formation on the Cell Surface
    Desai, B.
    Ma, T.
    Zhu, J.
    Chellaiah, M. A.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 108 (01) : 272 - 284
  • [34] Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis
    Chen, Jianqiang
    Zhou, Jianding
    Lu, Jie
    Xiong, Hua
    Shi, Xueli
    Gong, Liang
    BMC CANCER, 2014, 14
  • [35] Rheostatic CD44 isoform expression and its association with oxidative stress in human malignant mesothelioma
    Chew, Shan Hwu
    Okazaki, Yasumasa
    Akatsuka, Shinya
    Wang, Shenqi
    Jiang, Li
    Ohara, Yuuki
    Ito, Fumiya
    Saya, Hideyuki
    Sekido, Yoshitaka
    Toyokuni, Shinya
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 106 : 91 - 99
  • [36] CD44 in hematological neoplasias
    Hertweck, Magdalena Katharina
    Erdfelder, Felix
    Kreuzer, Karl-Anton
    ANNALS OF HEMATOLOGY, 2011, 90 (05) : 493 - 508
  • [37] CD44: a validated target for improved delivery of cancer therapeutics
    Ghosh, Sukhen C.
    Alpay, Sultan Neslihan
    Klostergaard, Jim
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (07) : 635 - 650
  • [38] The biology and role of CD44 in cancer progression: therapeutic implications
    Chen, Chen
    Zhao, Shujie
    Karnad, Anand
    Freeman, James W.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [39] The potential of CD44 as a diagnostic and prognostic tool in oral cancer
    Emich, Helena
    Chapireau, David
    Hutchison, Iain
    Mackenzie, Ian
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2015, 44 (06) : 393 - 400
  • [40] Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status
    Kim, Hee Jeong
    Kim, Mi-Jung
    Ahn, Sei Hyun
    Son, Byung Ho
    Kim, Sung Bae
    Ahn, Jin Hee
    Noh, Woo Chul
    Gong, Gyungyub
    BREAST, 2011, 20 (01): : 78 - 85